Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

Market Cap	5.14B +17.5%
Revenue (ttm)	4.56B +52.5%
Net Income	141.43M -47.5%
EPS	0.46 -36.0%
Shares Out	299.43M
PE Ratio	37.35
Forward PE	n/a
Dividend	0.50 (2.78%)
Ex-Dividend Date	Sep 29, 2025

Volume	17,146,929
Open	17.98
Previous Close	17.98
Day's Range	17.10 - 17.98
52-Week Range	13.90 - 20.20
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHA:605077

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltitol a bulk sweetener produced from naturally occurring compounds in corn; erythritol, is produced by the enzymatic hydrolysis of starch into glucose, non...

• Industry: Chemicals
• Sector: Materials
• Founded: 2001
• Employees: 2,248
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 605077

Financial Performance

In 2025, SHA:605077's revenue was 4.19 billion, an increase of 49.15% compared to the previous year's 2.81 billion. Earnings were 200.30 million, a decrease of -25.40%.